Journal list Promote Sponsor
verified SJR 0,189 · Q3
Clinical Pulmonary Medicine
United States · Lippincott Williams and Wilk...
workspace_premium Q3 — Pulmonary and Respiratory Medicine lock Subscription

Clinical Pulmonary Medicine

Clinical Pulmonary Medicine is a journal indexed in SJR in Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine with an H index of 20. It has an SJR impact factor of 0,189 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,189.

Clinical Pulmonary Medicine focuses its scope in these topics and keywords: hypoxemic, vap, cpap, days, sleep, effect, period, chronic, imaging, improve, ...

ISSN: 1068-0640
Publisher: Lippincott Williams and Wilkins Ltd.
Category: Pulmonary and Respiratory Medicine
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,189 Q3
H-index 20
Acceptance rate pie_chart
43%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

0,189

H-index

20

Docs (year)

0

Docs 3y

47

Total refs

0

Cites 3y

21

Citable 3y

46

Cites/Doc 2y

0

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

ARDS Prevention, the New Bundle?

View more

Use of Inhaled Steroids in COPD

View more

Combination Therapy as the First-Line Treatment for Pulmonary Arterial Hypertension

View more

Chemotherapy-Induced Lung Disease

View more

Chemokines in Lung Cancer

View more

Challenges and Opportunities for Identifying Non-Small Cell Lung Cancer Biomarkers Using Bronchoscopy

View more

Can We Reduce Ventilator-associated Pneumonia by Performing Early Tracheostomy?

View more

Bronchoscopic Myths and Legends

View more

Bronchiectasis

View more

Biologics: Salvaging the Image of Chemotherapy for Lung Cancer

View more

Benzodiazepines in the ICU

View more

Back Again

View more
SHOW MORE ARTICLES

Asymptomatic Reactivation of Endobronchial Mycobacterium tuberculosis Found Incidentally During Esophageal Carcinoma Restaging

View more

"New" Bronchopulmonary Dysplasia

View more

Antimicrobial Stewardship (AMS) in the Community

View more

An Unusual Cause of Neonatal Unilateral Lung Opacification

View more

Acute Exacerbations of Interstitial Lung Disease

View more

Acute Exacerbation of Idiopathic Pulmonary Fibrosis

View more

A Thoracic Mass Discovered at Abdominal Imaging

View more

A Review of Lung Transplantation for Patients With a-1 Antitrypsin Deficiency

View more

A Rare Cause for a Mediastinal Lesion

View more

A Potentially Better Means of Preventing Recurrent Venous Thromboembolism Is on the Horizon

View more

A Peripherally Calcified Anterior Mediastinal Lesion - Not the Usual Culprit

View more

A Clinical Approach to Chronic Dyspnea

View more

FAQs